News

GlobalData on MSN5d
FDA approves Edwards’ TAVR system for asymptomatic aortic stenosis patients
Edwards’ SAPIEN 3 platform becomes the first TAVR system approved by the FDA for asymptomatic severe aortic stenosis patients ...
News Medical5d
Early TAVR shows greatest stroke reduction in patients aged 65 to 70
That said, patients aged 65-69 who underwent early TAVR derived the most benefits, with significant reduction in stroke risk (0% early TAVR vs. 13% CS) and had six times lower rate of death ...
Business Wire5d
Edwards TAVR Receives FDA Approval for Patients With Asymptomatic Severe Aortic Stenosis
--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) announced today that the U.S. Food and Drug Administration (FDA) has approved its transcatheter aortic valve replacement (TAVR) therapy, the ...
MedPage Today5d
DAPT After TAVR: Harm Bleeds Into Mortality Territory
WASHINGTON -- Beyond bleeding alone, a regimen of dual antiplatelet therapy (DAPT) after transcatheter aortic valve replacement (TAVR) was associated with excess mortality, based on observational ...
Healio6d
FDA approves first TAVR platform to treat severe asymptomatic aortic stenosis
Edwards Lifesciences’ TAVR platform is the first to be approved in this population. Edwards Lifesciences announced the FDA approved its transcatheter aortic valve replacement platform for ...
FierceBiotech5d
Edwards Lifesciences nets FDA approval opening up TAVR to patients before they show symptoms
Edwards Lifesciences has claimed a groundbreaking approval from the FDA that opens up its minimally invasive heart valve implants to patients before they begin to show cardiac symptoms. The ...